Genetic & Genomic MedicineClinical and Translational SciencePeer-reviewed
Allelic Variation in HLA-DRB1 is Associated with Development of Anti-Drug Antibodies in Cancer Patients Treated with Atezolizumab that are Neutralizing in Vitro
Christian Hammer, Jane Ruppel, Lynn A. Kamen…·Valerie E. Quarmby
This study identifies HLA-DRB1 and HLA-DQA1 alleles associated with anti-drug antibodies and neutralizing antibodies in atezolizumab-treated cancer patients.
15 citations